drugset
Drugs / JE-CV
last change Sep 2016 re-read 3 minutes ago

JE-CV

Vaccine

Developed for
Japanese encephalitis
Investigated by
Chulalongkorn University · Sanofi Pasteur, a Sanofi Company

Trials 1

today NCT02602652 · not/applicable
20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT02602652 Dec 2013 → Jul 2015 Japanese encephalitis Chulalongkorn University Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as JE-CV “JE-CV was administered.” PMID 27628323 ↗ Sep 2016
Modality Vaccine “JE-CV and SA14-14-2 vaccine are live-attenuated JE vaccines produced from the same virus strain.” PMID 27628323 ↗ Sep 2016